You are here

Knowledge Science

Primary tabs

The Knowledge Science working group is focused on exploring the advancement of knowledge science.

The mission of the Knowledge Science working group is to explore the advancement of knowledge science.

Members

Joyce Fedeczko Kathy Gilbeaux Maeryn Obley mdmcdonald mike kraft Siftar
tkm tom.mcginn

Email address for group

knowledge-science@m.resiliencesystem.org

Screening for COVID at hospital entry of limited benefit --new study

New data: Screening for COVID at hospital entry of limited benefit

Screening nearly 1 million patients, visitors, and healthcare workers at the entrance of a large hospital for COVID-19 symptoms, exposures, or travel was of limited benefit at considerable cost, finds a Yale study published yesterday in JAMA Internal Medicine.

.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Latest COVID-19 Variants Can Evade Vaccine Protection, According to New Data

Time Magazine

The Latest COVID-19 Variants Can Evade Vaccine Protection, According to New Data

New lab data suggest that vaccines and prior infections may not offer enough protection against several new COVID-19 variants cropping up in the U.S. and around the world.

Dr. David Ho, director of Columbia University’s Aaron Diamond AIDS Research Center, and his team reported the results from a set of studies published in the journal Nature. They showed how well some of the latest variants—BQ.1, BQ.1.1, XBB, and XBB.1, which were all derived from Omicron—are evading both vaccine-derived and infection-derived immunity.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Doctors are trying to understand why Covid Patients Coming Off Ventilators Can Take Weeks to Regain Consciousness

In March 2020, New York City’s hospitals filled up with patients desperately ill with Covid-19. In many cases, when their fluid-filled lungs could no longer give them oxygen, doctors sedated them and put them on ventilators.

The patients who recovered were taken off the machines and anesthesia. Within a day or so, their doctors expected them to wake up.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Analysis: The Pandemic Uncovered Ways to Speed Up Science

The pandemic highlighted broad problems in research: that many studies were hyped, error-ridden, or even fraudulent, and that misinformation could spread rapidly. But it also demonstrated what was possible.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Mild Covid victims had increased risk of blood clots-- British study

People who caught mild Covid had increased risk of blood clots, British study finds

People who caught mild cases of Covid-19 during the first year of the pandemic had a higher risk of developing blood clots than those who were not infected, according to a large study published by British scientists this week.

...

The scientists said their findings highlight the importance of monitoring even people who had mild Covid for cardiovascular disease over the long term.

...

 

 

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Omicron keeps finding new evolutionary tricks to outsmart our immunity

Here's why one SARS-CoV-2 variant still reigns supreme : Shots - Health News : NPR

...

Has the evolution of the virus finally started to ebb, possibly making it more predictable?

The answer — according to a dozen evolutionary biologists, virologists and immunologists interviewed by NPR — is no.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Ivermectin still nopt a good COVID-19 Treatment--large new trial

Ivermectin: Still on a Losing Streak as COVID-19 Treatment | MedPage Today

WASHINGTON -- There were no differences in relief from mild-to-moderate COVID-19 symptoms for patients on ivermectin versus placebo, according to the ongoing ACTIV-6 trial.

Among >1,000 vaccinated and unvaccinated patients, the median time to recovery was 12 days for those in the ivermectin group and 13 days in the placebo group, reported Matthew McCarthy, MD, of Weill Cornell Medicine in New York City, at IDWeek.

As a result, the hazard ratio for improvement in time to recovery was 1.07 (95% credible interval 0.96-1.17, posterior P=0.91), McCarthy and colleagues stated in JAMA, where the results were simultaneously published.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks